Brief: Can-Fite Submitted FDA Pediatric Plan To Allow Registration Of Piclidenoson

Can Fite Biopharma

18/08/2023 12:10

Aug 18 (Reuters) - Can Fite Biopharma Ltd  CANF.TA :
    * CAN-FITE SUBMITTED TO FDA A PEDIATRIC PLAN TO ALLOW
REGISTRATION
OF PICLIDENOSON FOR THE TREATMENT OF ADOLESCENTS WITH PSORIASIS
    * CAN FITE BIOPHARMA LTD - FDA ENCOURAGED COMPANY TO ENROLL
ADOLESCENT PATIENTS DUE TO PICLIDENOSON'S GOOD SAFETY PROFILE

Source text for Eikon:  ID:nBw9wBzxta 
Further company coverage:  CANF.TA